Author: Kuznik, B. I.; Smolyakov, Yu. N.; Shapovalov, Yu. K.; Shapovalov, K. G.; Lukyanov, S. A.; Parts, D. S.
Title: The State of Microcirculatory Hemodynamics in Patients with Moderate and Severe COVID-19 Cord-id: sii3aqkc Document date: 2021_9_20
ID: sii3aqkc
Snippet: Microcirculatory hemodynamic indexes (HI) were assessed in patients with moderate and severe COVID-19. In both groups, a significant increase in the absolute spectral indexes (HI1, HI2, and HI3) and the ratio of low-frequency to high-frequency component (HI1/HI3) was revealed. In the group of severe infection, only the “slow†index (low-frequency HI1) of microcirculatory hemodynamics was significantly lower. The oscillatory indices MAYER1-3 and RESP1-3 were reduced in patients of both groups
Document: Microcirculatory hemodynamic indexes (HI) were assessed in patients with moderate and severe COVID-19. In both groups, a significant increase in the absolute spectral indexes (HI1, HI2, and HI3) and the ratio of low-frequency to high-frequency component (HI1/HI3) was revealed. In the group of severe infection, only the “slow†index (low-frequency HI1) of microcirculatory hemodynamics was significantly lower. The oscillatory indices MAYER1-3 and RESP1-3 were reduced in patients of both groups. The aggravation of the disease course was accompanied by depression of the low-frequency index HI1. Regulatory shifts compensate for disturbances in microcirculatory processes in moderate COVID-19, but severe course was associated with their decompensation.
Search related documents:
Co phrase search for related documents- acute ards respiratory distress syndrome and lmwh low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
- acute ards respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
- acute ards respiratory distress syndrome and lopinavir ritonavir hydroxychloroquine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute ards respiratory distress syndrome and low frequency: 1
- acute ards respiratory distress syndrome and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute ards respiratory distress syndrome and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute ards respiratory distress syndrome and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- acute ards respiratory distress syndrome and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- acute sars coronavirus cause respiratory syndrome and lopinavir ritonavir: 1, 2, 3
- acute sars coronavirus cause respiratory syndrome and lopinavir ritonavir hydroxychloroquine: 1, 2
- acute sars coronavirus cause respiratory syndrome and lopinavir ritonavir hydroxychloroquine include: 1
- acute sars coronavirus cause respiratory syndrome and low molecular weight: 1
- acute sars coronavirus cause respiratory syndrome and low molecular weight heparin: 1
- acute sars coronavirus cause respiratory syndrome and lung disease: 1, 2, 3, 4, 5
- acute sars coronavirus cause respiratory syndrome and lung tissue: 1, 2, 3, 4
- additional measure and administration rate: 1
- additional measure and lung tissue: 1
- adhesion molecule and low frequency: 1
- adhesion molecule and lung disease: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date